
CVSA Stock Forecast & Price Target
CVSA Analyst Ratings
Bulls say
Covista is a financially sound company with a positive outlook due to its diverse portfolio of universities, strong performance, and expansion plans. Despite potential challenges, such as a slowdown in enrollment and regulatory issues, the company's executive appointments and compensation structure suggest a confident outlook for the future.
Bears say
Covista is facing several challenges, including execution issues and uncertainty around the Chamberlain segment, increased regulatory scrutiny from the Department of Education, and a potential decrease in demand for college education. With a focus on labor shortages and upskilling trends, Covista's clinical healthcare-focused institutions may not be able to attract enough students to sustain its growth, especially with the availability of alternative options for higher education. Additionally, the company's exposure to new loan caps and potential difficulties in M&A could further limit its growth potential.
This aggregate rating is based on analysts' research of Adtalem Global Education Inc and is not a guaranteed prediction by Public.com or investment advice.
CVSA Analyst Forecast & Price Prediction
Start investing in CVSA
Order type
Buy in
Order amount
Est. shares
0 shares